inn

(redirected from Bortezomib)
Also found in: Dictionary, Medical, Legal, Encyclopedia, Wikipedia.
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • noun

Synonyms for inn

Synonyms for inn

a hotel providing overnight lodging for travelers

References in periodicals archive ?
These findings demonstrate that patients with relapsed multiple myeloma treated with Kyprolis lived twice as long without disease worsening as those treated with bortezomib.
The safety and efficacy of Farydak in combination with bortezomib and dexamethasone was demonstrated in 193 clinical trial participants with multiple myeloma who received at least two prior treatments that included bortezomib and an immunomodulatory agent.
Lymphoma - Pre-Clinical - Chemotherapy and Biologic Agents: Poster II Abstract #: 2765 Title: The Irreversible Proteasome Inhibitor Carfilzomib Interacts Synergistically with the Selective HDAC6 Inhibitor ACY-1215 in ABC- and GC-DLBCL and Mantle Cell Lymphoma Sensitive or Resistant to Bortezomib Authors Affiliated with the Following Institutions: Virginia Commonwealth University and University of Rochester Description: These findings indicate that combining the selective HDAC6 inhibitor ACY-1215 with carfilzomib (CFZ) synergistically in preclinical models induces apoptosis in low- and high-risk diffuse large B-cell lymphoma (DLBCL) and in mantle cell lymphoma (MCL) cells through a JNK-dependent process in association with G2M arrest, down-regulation of HR23B, and induction of DNA damage.
Jane Griffiths, Company Group Chairman, Janssen Europe, Middle-East, Africa, commented: "This positive opinion is a decisive step in making subcutaneous bortezomib available to all patients who suffer from multiple myeloma.
In ENDEAVOR, the rates for cardiac and renal failure were higher in the Kyprolis arm versus the bortezomib arm.
c]ABenefit of bortezomib, in combination with melphalan and prednisone (VMP), seen across multiple patient subgroups regardless of subsequent extensive therapy
8 months in patients who received >2 prior lines of therapy, including bortezomib and IMiD(1)[[/para]]
Second Malignancies Among Elderly Multiple Myeloma Patients Exposed to Bortezomib and Other Treatments: An Analysis of the US Seer-Medicare Linked Database
90 percent of patients had prior bortezomib exposure and 26 percent were bortezomib refractory, 88 percent had previous lenalidomide exposure, 62 percent had prior thalidomide exposure and 12 percent had prior carfilzomib/marizomib exposure.
Combination study of venetoclax with bortezomib and dexamethasone showed 83 percent overall response rate in bortezomib-naive patients and a 63 percent overall response rate in bortezomib-sensitive patients
Drug: Liposomal Doxorubicin, Bortezomib, etravirine, Rilpivirine, Darunavir, Telaprevir
A Phase 3 Prospective Randomized International Study (MMY-3021) Comparing Subcutaneous and Intravenous Administration of Bortezomib In Patients with Relapsed Multiple Myeloma.
al, pre-published online April 4, 2012, Zalicus researchers, in collaboration with the Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, have discovered that adenosine A2A and beta-2 adrenergic receptor agonists are highly synergistic and selective novel agents that enhance glucocorticoid activity in B-cell malignancies such as multiple myeloma and, importantly, can synergize in combination with current multiple myeloma treatment regimens such as melphalan, lenalidomide, bortezomib and doxorubicin.